Filter by:
Caption
Inside Virginia’s Rise to Biopharma Prominence
As the world continues to struggle with drug supply chains and critical shortages, clusters of activity have emerged to move the needle of medication affordability and accessibility.
A Biopharma Moment Decades in the Making
John Newby is the CEO of Virginia Bio, the nonprofit statewide trade association that serves and promotes the life sciences industry in Virginia.
Growing a Biopharma Ecosystem
Eric Arocho is associate vice president at Eli Lilly and Company and the site lead on the company’s facility in Goochland County, announced last year.
Building a Sustainable Pharma Manufacturing Workforce
Recent major biopharmaceutical manufacturing announcements are positioning Virginia for a broader reshoring effort in the pharma industry. COVID-era supply chain disruptions and resulting shortages exposed the risks of over-reliance on overseas production for essential medicines.
Continuous Improvement
A pharmaceutical manufacturing innovation that came out of a Virginia university is changing the way medicines are made. The Commonwealth’s universities and the rest of its biopharma research community are making sure Virginia is ready to make the medicines of the future.
Enabling Innovation
Would more men try to prevent unintended pregnancies if their choices for contraception went beyond a condom or vasectomy?
Behind the Effort to Bring Drug Manufacturing Back to U.S. Shores
In October 2025, shovels went into the ground in Elkton, marking the start of a $3 billion pharmaceutical expansion project that will add 400,000 square feet to Merck’s existing campus.
Richmond
The Communities at the Forefront of Virginia’s Biopharma Push: Greater Richmond
The Greater Richmond region is in the middle of the greatest population growth in its history.
The Investments Behind a Biopharma Hotspot
A lot changed in Virginia’s life sciences industry in the space of about a month last fall. Between Sept. 16 and Oct. 20, biopharmaceutical manufacturing giants Eli Lilly and Company, AstraZeneca, and Merck & Co.
George Mason University’s Fuse at Mason Square opened for commercial use in 2024 and will open to students in fall 2025. The state-of-the-art building will house the university’s new School of Computing and host courses in AI and cybersecurity.
Bolstering Cyber Defenses Through Collaboration
In an era where cyberattacks threaten everything from bank accounts to national security, the need for cybersecurity has never been higher. In 2020, data breaches, ransomware, and other cybercrimes cost the United States over $4 billion in damages, according to the Federal Bureau of Investigation.
Hacking the Glass Ceiling
In an increasingly digital world where data breaches, ransomware attacks, and other cybercrimes are pervasive, a skilled cybersecurity workforce is more important than ever. Yet the industry grapples with a significant worker shortage.
